Skip to content
HomeLatest newsInnovationJohnson & Johnson honored in Fast Company’s top ten most innovative biotech companies
JLabs

Johnson & Johnson honored in Fast Company’s top ten most innovative biotech companies

Johnson & Johnson was honored as one of Fast Company’s top ten most innovative biotech companies. Johnson & Johnson was recognized for its incubation of medical startups. Learn more about the ranking on Fast Company’s website. Check out JLABS to learn more about how we support startups.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.